12 Of Japan’s 13 Drug Makers Expect Higher Profits This Year
This article was originally published in PharmAsia News
Executive Summary
All but one of Japan's 13 pharmaceutical companies are expected to see increased profits this year, according to national survey of drug makers. Only Astellas Pharma is expected to end the year lower than the year before. The survey of companies indicates they have been relatively immune to recent economic downturns. Another factor is seen in the government's schedule for reviewing drug prices, now not scheduled before April of next year. Drug makers Hisamitsu Pharmaceutical and Tsumura are expected to post double-digit profit increases this year. (Click here for more - a subscription may be required
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.